Olga Mitelman, MD MBA
About Olga Mitelman, MD MBA
Olga Mitelman, MD MBA, serves as the Senior Vice President and Head of Medical Affairs at Fulcrum Therapeutics. She has held various leadership roles in medical affairs at companies such as Sarepta Therapeutics, Biogen, Upsher-Smith Laboratories, and Johnson & Johnson.
Current Role at Fulcrum
Olga Mitelman serves as the Senior Vice President and Head of Medical Affairs at Fulcrum Therapeutics. She has held this position since 2021, contributing to the company's strategic direction in medical affairs. Her role involves overseeing medical strategies and ensuring alignment with the company's goals in the therapeutic landscape.
Previous Experience in Medical Affairs
Prior to her current role, Olga Mitelman worked at Sarepta Therapeutics as Head of Global Medical Affairs for six months in 2021. She also held significant positions at Biogen, where she served as Senior Director of Global Medical Hematology from 2015 to 2018 and as Director of Global Medical Neurology from 2014 to 2018. Her experience includes a role as Director of Medical Affairs for Epilepsy at Upsher-Smith Laboratories from 2012 to 2013, and as Associate Director of Medical Affairs at Johnson & Johnson from 2002 to 2006.
Educational Background
Olga Mitelman has a strong educational foundation in medicine and business. She studied at the University of Pennsylvania School of Medicine, where she earned her medical degree. Additionally, she attended The Wharton School, gaining an MBA. She completed her undergraduate studies at Williams College, where she achieved a Bachelor’s Degree.
Career Timeline
Olga Mitelman's career spans over two decades in the medical affairs sector. She began her career at Johnson & Johnson from 2002 to 2006. After that, she transitioned to Upsher-Smith Laboratories for a year, followed by a significant tenure at Biogen from 2014 to 2018. She then worked at Sarepta Therapeutics from 2018 to 2021 before joining Fulcrum Therapeutics in 2021.